Significance of the Myxovirus resistance A (MxA) gene - 123C>A single-nucleotide polymorphism in suppressed interferon ß induction of severe acute respiratory syndrome coronavirus infection

Journal of Infectious Diseases

Volumn 201, Issue 12, 2010, Pages 1899-1908

  Ching, Johannes Chi Yun ^a   Chan, Kelvin Yuen Kwong ^a   Lee, Eric Hing Leung ^a   Xu, Mei Shu ^a   Ting, Campbell Kam Po ^a   So, Thomas M K ^c   Sham, Pak C ^a   Leung, Gabriel M ^a   Peiris, Joseph S M ^b   Khoo, Ui Soon ^a  

^a Department of Pathology ^*  (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; NUCLEAR PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MYXOVIRUS RESISTANCE PROTEINS;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BINDING AFFINITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONAVIRUS; DISEASE COURSE; DISEASE PREDISPOSITION; EXTRACTION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE INDUCTION; GENE LINKAGE DISEQUILIBRIUM; GENE REPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HOUSEHOLD; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; RISK ASSESSMENT; SCHOOL CHILD; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS CARRIER; VIRUS INFECTION; GENETICS; IMMUNOLOGY; MIDDLE AGED; PROMOTER REGION; SARS CORONAVIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GTP-BINDING PROTEINS; HUMANS; IMMUNITY, INNATE; INTERFERON-ALPHA; INTERFERON-BETA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; YOUNG ADULT;

EID: 77952560927     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652799     Document Type: Article

References (42)

1. World Health Organization. Summary table of SARS cases by country, 1 November 2002 to 7 August 2003. http://www.who.int/csr/sars/country/2003-08-15/ en/index.html. Accessed 10 May 2010.
2. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med 2003; 349: 2431-2441.
3. Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome Coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007; 20: 660-694. (Pubitemid 47623772)
4. Chan VS, Chan KY, Chen Y, et al. Homozygous I.-SIGN (CLECAM) plays a protective role in SARS Coronavirus infection. Nat Genet 2006; 38: 38-46. (Pubitemid 43011880)
5. Chan KY, Ching JC, Xu MS, et al. Association of ICAM3 Genetic Variant with Severe Acute Respiratory Syndrome. J Infect Dis 2007; 196: 271-280. (Pubitemid 47047467)
6. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet 2003; 362: 293-294.
7. Stroher U, DiCaro A, Li Y, et al. Severe acute respiratory syndromerelated Coronavirus is inhibited by interferon- alpha. J Infect Dis 2004; 189: 1164-1167. (Pubitemid 38457239)
8. Hensley LE, Fritz LE, Jahrling PB, Karp CL, Huggins JW, Geisbert TW. Interferon-beta 1a and SARS Coronavirus replication. Emerg Infect Dis 2004;10: 317-319.
9. Tan EL, Ooi EE, Lin CY, et al. Inhibition of SARS Coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis 2004; 10: 581-586.
10. Sainz B, Jr., Mossel EC, Peters CJ, Garry RF. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated Coronavirus (SARS-CoV). Virology 2004; 329: 11-17.
11. Zhao H, De BP, Das T, Banerjee AK. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology 1996; 220: 330-338. (Pubitemid 26202356)
12. Landis H, Simon-Jodicke A, Kloti A, et al. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J Virol 1998; 72: 1516-1522. (Pubitemid 28116940)
13. Chieux V, Chehadeh W, Harvey J, Haller O, Wattre P, Hober D. Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. Virology 2001; 283: 84-92. (Pubitemid 32911512)
14. Gordien E, Rosmorduc O, Peltekian C, Garreau F, Brechot Q Kremsdorf D. Inhibition of hepatitis B virus replication by the interferoninducible MxA protein. J Virol 2001; 75: 2684-2691. (Pubitemid 32185032)
15. Hijikata M, Ohta Y, Mishiro S. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt-88) correlated with the response of hepatitis C patients to interferon. Intervirology 2000; 43: 124-127.
16. Hijikata M, Mishiro S, Miyamoto C, Furuichi Y, Hashimoto M, Ohta Y. Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro. Intervirology 2001; 44: 379-382. (Pubitemid 34114189)
17. Torisu H, Kusuhara K, Kira R, et al. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 2004; 62: 457-460. (Pubitemid 38200860)
18. Nakade K, Handa H, Nagata K. Promoter structure of the MxA gene that confers resistance to influenza virus. FEBS Lett 1997; 418: 315-318. (Pubitemid 27515947)
19. Furuyama H, Chiba S, Okabayashi T, et al. Single nucleotide polymorphisms and functional analysis of MxA promoter region in multiple sclerosis. J Neurol Sci 2006; 249: 153-157. (Pubitemid 44665920)
20. Fernandez-Arcas N, Blanco A, Gaitan MJ, Nyqvist M, Alonso A, ReyesEngel A. Differential transcriptional expresion of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment. Pharmacogenetics 2004; 14: 189-193. (Pubitemid 38373113)
21. Cheung CY, Poon LL, Ng IH, et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 2005; 79: 7819-7826.
22. Law HK, Cheung CY, Ng HY, et al. Chemokine up-regulation in SARScoronavirus-infected, monocyte-derived human dendritic cells. Blood 2005; 106: 2366-2374. (Pubitemid 41510809)
23. Reghunathan R, Jayapal M, Hsu LY, et al. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol 2005; 6: 2.
24. Spiegel M, Pichlmair A, Martinez-Sobrido L, et al. Inhibition of beta interferon induction by severe acute respiratory syndrome Coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 2005; 79: 2079-2086.
25. Weinstock-Guttman B, Tamano-Blanco M, Bhasi K, Zivadinov R, Ramanathan M. Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patients. J Neuroimmunol 2007; 182: 236-239.
26. Peng XM, Lei RX, Gu L, Ma HH, Xie QF, Gao ZL. Influences of MxA gene -88 G/T and IFN-gamma +874 A/T on the natural history of hepatitis B virus infection in an endemic area. Int J Immunogenet 2007; 34: 341-346. (Pubitemid 47383390)
27. Kong XF, Zhang XX, Gong QM, et al. MxA induction may predict sustained virologie responses of chronic hepatitis B patients with IFNalpha treatment. J Interferon Cytokine Res 2007; 27: 809-818.
28. Knapp S, Yee LJ, Frodsham AJ, et al. Polymorphisms in interferoninduced genes and the outcome of hepatitis C virus infection: roles of MxA OAS-1 and PKR. Genes Immun 2003; 4: 411-419. (Pubitemid 38967606)
29. Suzuki F, Arase Y, Suzuki Y, et al. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection. J Viral Hepat 2004; 11: 271-276. (Pubitemid 38658454)
30. Hamano E, Hijikata M, Itoyama S, et al. Polymorphisms of interferoninducible genes OAS-l and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun 2005; 329: 1234-1239. (Pubitemid 40568701)
31. He J, Feng D, de Vlas SJ, et al. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS-1 and MxA genes: a casecontrol study. BMC Infect Dis 2006; 6: 106. (Pubitemid 44251444)
32. Chan KY, Liu W, Long JR, et al. Functional polymorphisms in the promoter of BRCA1 influence transcription and are associated with decreased risk for breast cancer in Chinese women. J Med Genet 2009; 46(l): 32-39.
33. Chan KY, Liu W, Long JR, et al. Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women. J Med Genet 2009; 46: 32-39.
34. Boston RC, Sumner AE. STATA: a statistical analysis system for examining biomedical data. Adv Exp Med Biol 2003; 537: 353-369. (Pubitemid 37549931)
35. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
36. Lussier MP, Cayouette S, Lepage PK, et al. MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. J Biol Chem 2005; 280: 19393-19400. (Pubitemid 41379647)
37. Leung GM, Rainer TH, Lau FL, et al. A clinical prediction rule for diagnosing severe acute respiratory syndrome in the emergency department. Ann Intern Med 2004; 141: 333-342.
38. Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med 2004; 141: 662-673.
39. Mibayashi M, Nakad K, Nagata K. Promoted cell death of cells expressing human MxA by influenza virus infection. Microbiol Immunol 2002; 46: 29-36. (Pubitemid 34101084)
40. Salomon R, Staeheli P, Kochs G, et al. Mx1 gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle 2007; 6: 2417-2421. (Pubitemid 350058695)
41. Tumpey TM, Szretter KJ, Van Hoeven N, et al. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 2007; 81: 10818-10821.
42. Zeng H, Goldsmith C, Thawatsupha P, et al. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J Virol 2007; 81: 12439-12449.